Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies-Reference-Cited by-同舟云学术

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

Published:2022-04-19 Issue:6 Volume:5 Page:2200030
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Advanced Therapeutics

Author:

Rumsey John W.¹,Lorance Case¹,Jackson Max¹,Sasserath Trevor¹,McAleer Christopher W.¹,Long Christopher J.¹,Goswami Arindom²,Russo Melissa A.³,Raja Shruti M.³,Gable Karissa L.³,Emmett Doug³,Hobson‐Webb Lisa D.³,Chopra Manisha⁴,Howard James F.⁴,Guptill Jeffrey T.³,Storek Michael J.⁵,Alonso‐Alonso Miguel⁶,Atassi Nazem⁶,Panicker Sandip⁷,Parry Graham⁷,Hammond Timothy⁸,Hickman James J.¹²^ORCID

Affiliation:

1. Hesperos, Inc 12501 Research Parkway, Suite 100 Orlando FL 32826 USA

2. NanoScience Technology Center University of Central Florida Orlando FL 32826 USA

3. Division of Neuromuscular Disease, Department of Neurology Duke University Medical Center Box 3403 Durham NC 27702 USA

4. Department of Neurology, The University of North Carolina – Chapel Hill School of Medicine Chapel Hill NC 37516 USA

5. Immunology and Inflammation Sanofi 225 2nd Ave Waltham MA 02451 USA

6. Neurology Early Development Sanofi 50 Binney Street Cambridge MA 02142 USA

7. Bioverativ a Sanofi company 225 2nd Ave Waltham MA 02451 USA

8. Neurological Diseases Sanofi 49 New York Ave Framingham MA 01701 USA

Publisher

Wiley

Subject